https://www.selleckchem.com/pr....oducts/Dasatinib.htm
7444, P less then 0.0001) and therapeutic response of ARN (R2=0.999, P less then 0.0001). Therefore, our AI algorithm has a potential application in the clinical aided diagnosis of ARN, evaluation of ARN severity, and treatment response monitoring.Dysregulated crosstalk between different signaling pathways contributes to tumor development, including resistance to cancer therapy. In the present study, we found that the mitogen-activated extracellular signal-regulated kinase (MEK) inhibitor trametinib failed to suppress the proliferatio
Like
Comment
Share
